AAAAAA

   
Results: 1-17 |
Results: 17

Authors: GRIFFITHS RI BLEECKER GC JABS DA DIETERICH DT COLESON L WINTERS D WOLITZ R STEINBERG EP
Citation: Ri. Griffiths et al., PHARMACOECONOMIC ANALYSIS OF 3 TREATMENT STRATEGIES FOR CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS, PharmacoEconomics, 13(4), 1998, pp. 461-474

Authors: GRIFFITHS RI HYMAN CL MCFARLANE SI SAURINA GR ANDERSON JE OBRIEN T POPPER C MCGRATH MM HERBERT RJ SIERRA MF
Citation: Ri. Griffiths et al., MEDICAL-RESOURCE USE FOR SUSPECTED TUBERCULOSIS IN A NEW-YORK-CITY HOSPITAL, Infection control and hospital epidemiology, 19(10), 1998, pp. 747-753

Authors: RABENECK L GRIFFITHS RI GUZMAN G CROMWELL DM STRAUSS MJ ROBINSON JW WINSTON B LI T GRAHAM DY
Citation: L. Rabeneck et al., MANAGEMENT OF H-PYLORI-INFECTED ULCER PATIENTS FOLLOWING INITIAL THERAPY - COSTS AND OUTCOMES OF ALTERNATIVE APPROACHES, Gastroenterology, 112(4), 1997, pp. 37-37

Authors: STEINBERG EP GRIFFITHS RI BLEECKER GC
Citation: Ep. Steinberg et al., COSTS AND OUTCOMES OF ALTERNATIVE APPROACHES TO TREATING CYTOMEGATOVIRUS (CMV) RETINITIS IN PERSONS WITH AIDS (PWA), Investigative ophthalmology & visual science, 37(3), 1996, pp. 4161-4161

Authors: DORSEY JH HOLTZ PM GRIFFITHS RI MCGRATH MM STEINBERG EP
Citation: Jh. Dorsey et al., COSTS AND CHARGES ASSOCIATED WITH 3 ALTERNATIVE TECHNIQUES OF HYSTERECTOMY, The New England journal of medicine, 335(7), 1996, pp. 476-482

Authors: GRIFFITHS RI BERGER PJ
Citation: Ri. Griffiths et Pj. Berger, FUNCTIONAL-DEVELOPMENT OF THE SHEEP DIAPHRAGMATIC LIGAMENT, Journal of physiology, 492(3), 1996, pp. 913-919

Authors: GRIFFITHS RI ANDERSON GF POWE NR OLIVERAS E HERBERT RJ GRANT CC DAVIDSON BL
Citation: Ri. Griffiths et al., ECONOMIC-IMPACT OF IMMUNIZATION AGAINST ROTAVIRUS GASTROENTERITIS - EVIDENCE FROM A CLINICAL-TRIAL, Archives of pediatrics & adolescent medicine, 149(4), 1995, pp. 407-414

Authors: POWE NR GRIFFITHS RI
Citation: Nr. Powe et Ri. Griffiths, THE CLINICAL-ECONOMIC TRIAL - PROMISE, PROBLEMS, AND CHALLENGES, Controlled clinical trials, 16(6), 1995, pp. 377-394

Authors: POWE NR GRIFFITHS RI WATSON AJ ANDERSON GF DELISSOVOY G GREER JW HERBERT RJ MILAM RA WHELTON PK
Citation: Nr. Powe et al., EFFECT OF RECOMBINANT ERYTHROPOIETIN ON HOSPITAL ADMISSIONS, READMISSIONS, LENGTH OF STAY, AND COSTS OF DIALYSIS PATIENTS, Journal of the American Society of Nephrology, 4(7), 1994, pp. 1455-1465

Authors: BASS EB STEINBERG EP PITT HA GRIFFITHS RI LILLEMOE KD SABA GP JOHNS C
Citation: Eb. Bass et al., COMPARISON OF THE RATING-SCALE AND THE STANDARD GAMBLE IN MEASURING PATIENT PREFERENCES FOR OUTCOMES OF GALLSTONE DISEASE, Medical decision making, 14(4), 1994, pp. 307-314

Authors: GRIFFITHS RI BALDWIN J BERGER PJ
Citation: Ri. Griffiths et al., METABOLIC DEVELOPMENT OF THE SHEEP DIAPHRAGM DURING FETAL AND NEWBORNLIFE, Respiration physiology, 95(3), 1994, pp. 337-347

Authors: DELISSOVOY G POWE NR GRIFFITHS RI WATSON AJ ANDERSON GF GREER JW HERBERT RJ EGGERS PW MILAM RA WHELTON PK
Citation: G. Delissovoy et al., THE RELATIONSHIP OF PROVIDER ORGANIZATIONAL STATUS AND ERYTHROPOIETINDOSING IN END-STAGE RENAL-DISEASE PATIENTS, Medical care, 32(2), 1994, pp. 130-140

Authors: GRIFFITHS RI POWE NR GASKIN DJ ANDERSON GF DELISSOVOY GV WHELTON PK
Citation: Ri. Griffiths et al., THE PRODUCTION OF DIALYSIS BY FOR-PROFIT VERSUS NOT-FOR-PROFIT FREESTANDING RENAL DIALYSIS FACILITIES, Health services research, 29(4), 1994, pp. 473-487

Authors: POWE NR GRIFFITHS RI BASS EB
Citation: Nr. Powe et al., COST IMPLICATIONS TO MEDICARE OF RECOMBINANT ERYTHROPOIETIN THERAPY FOR THE ANEMIA OF END-STAGE RENAL-DISEASE, Journal of the American Society of Nephrology, 3(10), 1993, pp. 1660-1671

Authors: POWE NR GRIFFITHS RI ANDERSON GF DELISSOVOY G WATSON AJ GREER JW HERBERT RJ WHELTON PK
Citation: Nr. Powe et al., MEDICARE PAYMENT POLICY AND RECOMBINANT ERYTHROPOIETIN PRESCRIBING FOR DIALYSIS PATIENTS, American journal of kidney diseases, 22(4), 1993, pp. 557-567

Authors: BASS EB POWE NR GOODMAN SN GRAZIANO SL GRIFFITHS RI KICKLER TS WINGARD JR
Citation: Eb. Bass et al., EFFICACY OF IMMUNE GLOBULIN IN PREVENTING COMPLICATIONS OF BONE-MARROW TRANSPLANTATION - A METAANALYSIS, Bone marrow transplantation, 12(3), 1993, pp. 273-282

Authors: GRIFFITHS RI BASS EB POWE NR ANDERSON GF GOODMAN S WINGARD JR
Citation: Ri. Griffiths et al., FACTORS INFLUENCING 3RD-PARTY PAYER COSTS FOR ALLOGENEIC BMT, Bone marrow transplantation, 12(1), 1993, pp. 43-48
Risultati: 1-17 |